Influence of maternal pre-eclampsia on VEGF/PlGF heterodimer levels in preterm infants

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 28, Issue 18, 2015, Pages 2166-2171

  Hentges, Cláudia R ^a   Silveira, Rita C ^a   Ferrelli, Régis S ^a   Procianoy, Renato S ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Angiogenic factors; antiangiogenic factors; PlGF; preeclampsia; prematurity; VEGF; VEGF PlGF heterodimer

Indexed keywords

HETERODIMER; HOMODIMER; VASCULOTROPIN; BIOLOGICAL MARKER; MEMBRANE PROTEIN; PIGF PROTEIN, HUMAN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ANGIOGENESIS; ARTICLE; AUTOIMMUNE DISEASE; BIRTH WEIGHT; BLOOD SAMPLING; CONGENITAL MALFORMATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INBORN ERROR OF METABOLISM; INFANT; MAJOR CLINICAL STUDY; MULTIPLE PREGNANCY; PREECLAMPSIA; PRIORITY JOURNAL; BLOOD; CASE CONTROL STUDY; MALE; NEWBORN; PREGNANCY; PREMATURITY;

BIOMARKERS; BIRTH WEIGHT; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MALE; MEMBRANE PROTEINS; PRE-ECLAMPSIA; PREGNANCY; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84942815463     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2014.980231     Document Type: Article

References (31)

1. Cerdeira AS, Karumanchi SA. Angiogenic factors in preeclampsia and related disorders. Cold Spring Harb Perspect Med 2012. doi: 10.1101/cshperspect.a006585
2. Muy-Rivera M, Vadachkoria S, Woelk GB, et al. Maternal plasma VEGF, sVEGF-R1, and PlGF concentrations in preeclamptic and normotensive pregnant zimbabwean women. Physiol Res 2005; 54: 611-22
3. Ribatti D. The discovery of placental growth factor and its role in angiogenesis: a historical review. Angiogenesis 2008; 11: 215-21
4. Silasi M, Cohen B, Karamunchi SA, Rana S. Abnormal placentaion, angiogenic factors, and the pathogenesis of preeclampsia. Obstet Gynecol Clin N Am 2010; 37: 239-53
5. Lam C, Lim K, Karumanchi SA. Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia. Hypertension 2005; 46: 1077-85
6. Dewerchin M, Carmeliet P. PlGF: a multistaking cytokine with disease-restricted activity. Cold Spring Harb Perspect Med 2012. doi: 10.1101/cshperspect.a011056
7. Cetinkaya M, Özkan H, Köksal N, et al. Neonatal outcomes of premature infants born to preeclamptic mothers. J Matern Fetal Neonatal Med 2010; 23: 425-30
8. Basso O, Rasmussen S, Weinberg CR, et al. Trends in fetal and infant survival following preeclampsia. JAMA 2006; 296: 1357-62
9. Rugolo LMSS, Bentlin MR, Petean CE. Preeclampsia: effect on the fetus and newborn. NeoReviews 2011; 12: e198-206
10. Jelin AC, Cheng YW, Shaffer BL, et al. Early-onset preeclampsia and neonatal outcomes. J Matern Fetal Neonatal Med 2010; 23: 389-92
11. Wang A, Holston AM, Fu KF, et al. Circulating anti-angiogenic factors during hypertensive pregnancy and increased risk of respiratory distress syndrome in preterm neonates. J Matern Fetal Neonatal Med 2012; 25: 1447-52
12. Ozkan H, Cetinkaya M, Koksal N. Increased incidence of bronchopulmonary dysplasia in preterm infants exposed to preeclampsia. J Matern Fetal Neonatal Med 2012; 25: 2681-5
13. Tang JR, Karumanchi SA, Seedorf G, et al. Excess soluble vascular endothelial growth factor receptor-1 in amniotic fluid impairs lung growth in rats: linking preeclampsia with bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 2012; 302: L36-46
14. Hansen AR, Barnés CM, Folkman J, McElrath TF. Maternal preeclampsia predicts the development of bronchopulmonary dysplasia. J Pediatr 2010; 156: 532-6
15. Ozkan H, Cetinkaya M, Koksal N, et al. Maternal preeclampsia is associated with an increased risk of retinopathy of prematurity. J Perinat Med 2011; 39: 523-7
16. Tsao PN, Wei SC, Su YN, et al. Excess soluble fms-like tyrosine kinase 1 and low platelet counts in premature neonates of preeclamptic mothers. Pediatrics 2005; 116: 468-72
17. Procianoy RS, Silveira RC, Mussi-Pinhata MM, et al. Sepsis and neutropenia in very low birth weight infants delivered of mothers with preeclampsia. J Pediatr 2010; 157: 434-8
18. Cetinkaya M, Ozkan H, Koksal N. Maternal preeclampsia is associated with increased risk of necrotizing enterocolitis in preterm infants. Early Hum Dev 2012; 88: 893-8
19. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005; 365: 785-99
20. Alexander GR, Himes JH, Kaufman RB, et al. A United States National reference for fetal growth. Obstet Gynecol 1996; 87: 163-8
21. Eklund A. Beeswarm: the bee swarm plot, an alternative to stripchart. R package version 0.1.1, 2011. Available from: http://CRAN.R-project.org/package=beeswarm [last accessed 10 jun 2014]
22. Furuya M, Kurasawa K, Nagahama K, et al. Disrupted balance of angiogenic and antiangiogenic signaling in preeclampsia. J Pregnancy 2011; 2011: 123717
23. Eriksson A, Cao R, Pawliuk R, et al. Placenta growth factor-1 antagonizes VEGF-induced angiogenesis and tumor growth by the formation of functionally inactive PlGF-1/VEGF heterodimers. Cancer Cell 2002; 1: 99-108
24. Cho GJ, Roh GS, Kim HJ, et al. Differential expression of placenta growth factors and their receptors in the normal and pregnancy-induced hypertensive human placentas. J Korean Med Sci 2003; 18: 402-8
25. Stefanini MO, Wu FTH, Gabhann FM, Popel AS. A compartment model of VEGF distribution in blood, healthy and diseased tissues. BMC Syst Biol 2008; 2: 77
26. DiSalvo J, Bayne ML, Conn G, et al. Purification and characterization of a naturally occurring vascular endothelial growth factor/placental growth factor heterodimer. J Biol Chem 1995; 270: 7717-23
27. Cao Y, Chen H, Zhou L, et al. Heterodimers of placental growth factor/vascular endothelial growth factor: endothelial activity, tumor cell expression, and high affinity binding to Flk-1/KDR. J Biol Chem 1996; 271: 3154-62
28. De Falco S. The discovery of placenta growth factor and its biological activity. Exp Mol Med 2012; 44: 1-9
29. Asvold BO, Vatten LJ, Romundstad PR, et al. Angiogenic factors in maternal circulation and the risk of severe fetal growth restriction. Am J Epidemiol 2011; 173: 630-9
30. Taki A, Abe M, Komaki M, et al. Expression of angiogenesis-related factors and inflammatory cytokines in placenta and umbilical vessels in pregnancies with preeclampsia and chorioamnionitis/funisitis. Congenit Anom (Kyoto) 2012; 52: 97-103
31. Malamitsi-Puchner A, Tziotis J, Protonotariou E, et al. Angiogenic factors in the perinatal period: diversity in biological functions reflected in their serum concentrations soon after birth. Ann N Y Acad Sci 2000; 900: 169-73